The first goal of the National HIV/AIDS Strategy (NHAS) is to “reduce new infections.” In order to monitor progress toward this goal, the Centers for Disease Control and Prevention (CDC) and the Office of National AIDS Policy will be looking…
On November 16, 2016, TAG held a community webinar on advocacy for TB R&D funding. This webinar builds upon TAG's annual Report on Tuberculosis Research Funding Trends to begin discussion on next steps for TB R&D funding advocacy into 2017.…
July 13, 2016 The consequences of stigma among people living with and vulnerable to HIV infection are significant and far-reaching. Stigma is frequently cited as a significant barrier to successful pre-exposure prophylaxis (PrEP) awareness, access and utilization. Despite having been…
On Sunday February 21, 2016 in Boston, the AIDS Treatment Activists Coalition, AVAC, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research. The workshop has become an annual event that takes place immediately…
February 2, 2016 In an alarming shakeup to the HIV/AIDS community, the U.S. Congress dropped annual budget language that allocated 10% of the National Institutes of Health (NIH) yearly funding towards HIV/AIDS research. The sudden reallocation of resources for…
The 2016 elections will shape the work of many HIV prevention policy advocates as we continue to push for broader access to comprehensive services for all priority populations. With impending changes in federal and state leadership fast approaching, HIV advocates,…
RELATED: Toward Comprehensive HIV Prevention Service Delivery in the United States: An Action Plan December 18, 2015 A collaboration between Treatment Action Group and the HIV Prevention Justice Alliance, this webinar discusses the current state of the HIV prevention toolbox…
December 8, 2015 DOWNLOAD: HCV Webinar #1: The Cost of Production for HCV Treatment Slides Presenter: Dr. Andrew Hill, Senior Research Fellow, Department of Pharmacology and Therapeutics, Liverpool University, United Kingdom Description: New HCV drugs, called direct-acting antivirals (DAAs),…
On December 4, 2015, in Cape Town, South Africa, Treatment Action Group, Harvard Medical School, Partners In Health, Treatment Action Campaign, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference in Barcelona. The symposium,…